Oxytocin and Other Drugs acting on Uterus SN 1. Oxytocics* - classify*, uses, adverse effects; enumerate, clinical indications of each agent; Oxytocin and Prostaglandin Analogue - compare and contrast as oxytocics 2. Ergometrine in PPH - pharamacological basis, Contraindications to use of Ergometrine 3. Oxytocin and Ergometrine - compare and contrast*** 4. Why is Oxytocin used for Induction of Labour and not Methylergometrine. I have exam explain imp in simple language with more content

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
I have gathered sufficient reference material. Now I'll write the comprehensive exam-oriented answer.

Drugs Acting on the Uterus - Complete Exam Notes


SN 1: OXYTOCICS - Classification, Uses, Adverse Effects & Clinical Indications

What are Oxytocics?

Oxytocics (uterine stimulants) are drugs that stimulate rhythmic or sustained contractions of the uterus. The word comes from Greek - "oxys" (swift) + "tokos" (birth).

CLASSIFICATION OF OXYTOCICS

ClassAgents
A. Posterior pituitary hormoneOxytocin (Syntocinon)
B. Ergot alkaloidsErgometrine (Ergonovine), Methylergometrine (Methergine)
C. ProstaglandinsPGE2 - Dinoprostone; PGE1 analogue - Misoprostol; PGF2α analogue - Carboprost (15-methyl PGF2α)
D. MiscellaneousQuinine (weak), Sparteine (rarely used)

A. OXYTOCIN

Source & Nature

  • Nonapeptide hormone secreted by the posterior pituitary (hypothalamus synthesizes, posterior pituitary releases)
  • Available as synthetic oxytocin (identical to natural)

Mechanism of Action

  • Binds to Gq-coupled oxytocin receptors (OTR) on myometrial cells
  • Activates phospholipase C → IP3 → Ca²⁺ release from SR + increased Ca²⁺ entry
  • Increased intracellular Ca²⁺ → activates myosin light chain kinase (MLCK) → myometrial contraction
  • Sensitivity increases dramatically at term due to upregulation of OTRs (estrogen increases receptors; progesterone decreases them)

Pharmacokinetics

  • Route: IV (for induction), IM (for PPH)
  • Half-life: ~3-5 minutes (very short - inactivated by oxytocinase)
  • NOT given orally (destroyed by gut peptidases)
  • Onset IV: immediate; IM: 3-5 minutes

Uterine Effects

  • Low doses (physiological): rhythmic, coordinated contractions - mimics normal labour
  • High doses: sustained tonic contraction (spasm) - dangerous
  • Effect is dose-dependent and estrogen-dependent (works well near term)
  • At term - very sensitive; in early pregnancy - relatively insensitive (progesterone dominance)

Clinical Indications / Uses

  1. Induction of labour (at/near term, cervix ripe) - gold standard
  2. Augmentation of labour (sluggish uterine activity)
  3. Prevention of PPH (post-delivery IM or IV infusion)
  4. Treatment of PPH - IV infusion
  5. Management of incomplete abortion (helps expel products)
  6. Oxytocin challenge test (OCT) - fetal well-being assessment

Adverse Effects

  • Water intoxication (ADH-like effect) - most important; hyponatremia, convulsions
  • Uterine hyperstimulation / tetanic contraction - fetal distress, uterine rupture
  • Fetal hypoxia (due to sustained contraction reducing placental blood flow)
  • Hypotension (at high IV doses - vasodilation)
  • Nausea, vomiting

Contraindications

  • Cephalopelvic disproportion
  • Fetal malpresentation
  • Previous uterine scar (relative C/I)
  • Placenta praevia

B. ERGOT ALKALOIDS

Ergometrine (Ergonovine) and Methylergometrine (Methergine)

Source: Ergot fungus (Claviceps purpurea)
Mechanism of Action:
  • Act on α-adrenergic receptors and serotonin (5-HT) receptors on the uterus
  • Produce sustained tonic contraction (not rhythmic) of the uterus
  • The contraction is powerful and prolonged - entire uterus contracts like a clamp
Pharmacokinetics:
PropertyErgometrineMethylergometrine
RouteIV/IM/OralIM/Oral
Onset (IM)2-5 min2-5 min
Onset (IV)ImmediateImmediate
Duration45 min - 3 hoursSimilar
BioavailabilityGood orallyGood orally
Clinical Indications:
  1. PPH (Postpartum Haemorrhage) - primary use (IM after delivery of placenta)
  2. Subinvolution of uterus - promotes uterine involution postpartum
  3. Management of incomplete abortion
Why NOT used for induction of labour:
  • Causes TONIC (sustained, non-rhythmic) contraction → fetal hypoxia/asphyxia
  • Dangerous for the fetus
  • Causes hypertension (vasoconstriction)
Adverse Effects:
  • Hypertension (vasoconstriction via α-receptors and 5-HT receptors) - MAJOR concern
  • Nausea, vomiting
  • Headache, dizziness
  • Ergotism (with prolonged use): peripheral vascular spasm, gangrene, hallucinations (rare with modern use)
  • Coronary artery spasm (angina)

C. PROSTAGLANDINS

PGE2 - Dinoprostone (Prostin E2)

  • Cervical ripening (gel/pessary/tablet) and induction of labour
  • Mid-trimester termination of pregnancy

PGE1 analogue - Misoprostol (Cytotec, Oxaprost)

  • Cheap, heat-stable (no refrigeration needed) - ideal for developing countries
  • Routes: oral, sublingual, vaginal, rectal
  • Uses: induction of labour, medical abortion (with mifepristone), PPH
  • SE: fever, shivering, diarrhoea, uterine hyperstimulation

PGF2α analogue - Carboprost (15-methyl PGF2α; Hemabate)

  • Intractable PPH unresponsive to oxytocin and ergometrine
  • Dose: 250 mcg IM every 15-90 min (max 8 doses)
  • SE: Bronchoconstriction (C/I in asthma), diarrhoea, fever, hypertension

SN 1 (continued): OXYTOCIN vs PROSTAGLANDIN ANALOGUE - Compare and Contrast as Oxytocics

FeatureOxytocinProstaglandins (e.g., Misoprostol)
NatureNonapeptide hormoneModified arachidonic acid derivatives
ReceptorOxytocin receptor (Gq-coupled)EP/FP receptors (Gs and Gq)
MechanismIP3 → Ca²⁺ release → MLCK activationcAMP and IP3 pathways → Ca²⁺
Type of contractionRhythmic, coordinated (mimics labour)Rhythmic but also promotes cervical ripening
Effect on cervixMinimal cervical ripeningExcellent cervical ripening (softening)
RouteIV/IM only (destroyed orally)Oral, sublingual, vaginal, rectal
StorageRequires refrigerationMisoprostol is heat-stable (no refrigeration)
TitrationEasily titratable (IV infusion)Less easy to titrate (oral/vaginal doses)
SensitivityOnly effective near term (estrogen-dependent)Effective at any gestational age
UsesInduction, augmentation, PPHInduction, MTP, cervical ripening, PPH
Side effectsWater intoxication, hypotensionFever, shivering, diarrhoea, bronchospasm (carboprost)
Use in early pregnancyRelatively ineffectiveHighly effective (MTP)
Use in asthmaSafeCarboprost contraindicated; misoprostol relatively safe
CostModerateMisoprostol is cheap
Key advantageEasy IV titration, physiological contractionCervical ripening, oral route, gestational age independence

SN 2: ERGOMETRINE IN PPH - Pharmacological Basis & Contraindications

What is PPH?

Postpartum haemorrhage = blood loss >500 mL after vaginal delivery or >1000 mL after C-section. Most common cause is uterine atony (80% cases).

Pharmacological Basis of Ergometrine in PPH

  1. Mechanism: Ergometrine acts on α-adrenergic and 5-HT receptors on uterine smooth muscle
  2. Effect: Produces powerful, sustained tonic contraction of the entire uterus (body + lower segment)
  3. This tonic contraction mechanically compresses and obliterates the blood vessels supplying the placental bed → stops bleeding
  4. Think of it as: the uterus acts like a "living ligature" clamping the blood vessels
  5. Onset: Rapid (2-5 min IM; immediate IV)
  6. Dose: Ergometrine 0.25 mg IM or slow IV; Methylergometrine 0.2 mg IM
Practical use in PPH (Syntometrine):
  • A combination of Oxytocin 5 IU + Ergometrine 0.5 mg (Syntometrine) is commonly given IM at delivery of anterior shoulder - combines the rapid onset of oxytocin with the prolonged effect of ergometrine.

Contraindications to Ergometrine

ContraindicationReason
Hypertension / Pre-eclampsia / EclampsiaErgometrine causes vasoconstriction → further raise in BP → stroke, pulmonary oedema
Heart disease / Cardiac patientsVasoconstriction increases cardiac workload; can cause coronary vasospasm
Peripheral vascular diseaseWorsens ischaemia
Induction/augmentation of labourCauses tonic contraction → fetal asphyxia, uterine rupture
Second/third stage not completedRisk of trapping placenta/fetus
Renal failure / Hepatic failureImpaired metabolism/excretion
MigraineErgot-related vasoconstriction worsens
SepsisRisk of gangrene due to peripheral vasoconstriction
Bronchial asthmaSome bronchospasm risk
Key exam point: The most important contraindication is HYPERTENSION (including PIH/pre-eclampsia). In hypertensive mothers with PPH, use oxytocin or carboprost instead.

SN 3: OXYTOCIN vs ERGOMETRINE - Compare and Contrast ★★★

FeatureOxytocinErgometrine / Methylergometrine
SourcePosterior pituitary (synthetic)Ergot alkaloid (Claviceps purpurea fungus)
NatureNonapeptideErgot alkaloid (indole compound)
ReceptorOxytocin receptor (Gq-GPCR)α-adrenergic + 5-HT receptors
Type of uterine contractionRhythmic, coordinated contractions (mimics normal labour - contract + relax)Sustained tonic contraction (entire uterus = one continuous clamp)
Sensitivity (gestational age)Near term only (requires estrogen-primed uterus with OTRs)Effective at any stage of pregnancy and postpartum
Effect on lower uterine segmentActs mainly on upper segmentActs on entire uterus including lower segment and cervix
Effect on blood vesselsCauses mild vasodilation (hypotension at high doses)Causes vasoconstriction (raises BP - dangerous in hypertension)
RouteIV infusion (induction), IM (PPH)IM, IV (slow), oral
Oral bioavailabilityNone (peptide - destroyed)Good (can be given orally)
Onset (IM)3-5 min2-5 min
DurationShort (half-life 3-5 min)Longer (45 min to 3 hours)
Effect on BPMild hypotension (high doses)Hypertension (vasoconstriction)
Effect on milk ejectionYes (milk let-down reflex)No
ADH-like effectYes (water retention)No
Use in labour induction✅ YES - drug of choice❌ NO - causes fetal asphyxia
Use in PPH✅ YES - first line✅ YES - effective
Use in hypertensive mother✅ SAFE❌ CONTRAINDICATED
Use in cardiac patientCaution (hypotension at high doses)❌ AVOID (coronary spasm)
Fetal safety during labour✅ Safe when properly dosed❌ Dangerous (tonic contraction → fetal hypoxia)
Key advantagePhysiological, titratable, safe for fetusLonger-acting, good for PPH, oral route available
Key disadvantageShort-acting, water intoxication, no oral useHypertension, tonic spasm, contraindicated in HTN

SN 4: Why Oxytocin is Used for Induction of Labour and NOT Methylergometrine ★

This is a classic "why" question. Here are the reasons explained simply:

Oxytocin produces RHYTHMIC contractions; Methylergometrine produces TONIC contractions

Normal labour requires:
  • Contractions that come and go (rhythmic)
  • Between contractions: uterus relaxes → blood flows to placenta → fetus gets O₂
  • Cervix dilates progressively
  • Baby descends safely
What Oxytocin does:
  • Mimics natural labour contractions - rhythmic, coordinated, with relaxation between
  • Strength and frequency can be titrated (increased/decreased via IV infusion)
  • Acts only on upper uterine segment - lower segment & cervix stay relaxed → baby can pass
  • Effect disappears quickly if stopped (half-life 3-5 min) - easy to manage complications
  • Works via physiological OT receptors
Why Methylergometrine CANNOT be used for induction:
ReasonExplanation
Tonic contractionUterus contracts continuously - no relaxation phase - placental blood flow stops → fetal hypoxia → asphyxia → stillbirth
Fetal dangerContinuous contraction compresses umbilical vessels - baby cannot get O₂
Cannot titrateNo IV infusion possible; long duration; cannot stop quickly once given IM
Acts on entire uterusLower segment also contracts - cervix doesn't dilate - obstructed labour
Causes hypertensionVasoconstriction - dangerous in labour
Uterine rupture riskTonic spasm in a scarred uterus = catastrophic
Not selective for upper segmentCervix contracts too - no descent of presenting part
Simple way to remember:
Oxytocin = a bouncer who opens and closes the door rhythmically - people can pass through. Methylergometrine = a bouncer who LOCKS the door shut - nobody can get out, and the baby is trapped without oxygen.

QUICK SUMMARY TABLE - All Oxytocics at a Glance

OxytocinErgometrineMisoprostolCarboprost
Induction of labour✅ 1st choice✅ (if cervix unripe)
PPH prevention
PPH treatment✅ 1st line✅ 2nd line✅ refractory PPH
MTP / abortionLimited✅ (with mifepristone)✅ (2nd trimester)
Cervical ripening
Safe in hypertension
Safe in asthma
Oral use

HIGH-YIELD EXAM POINTS TO MEMORIZE

  1. Oxytocin = rhythmic contractions + only near term + titrable IV + water intoxication
  2. Ergometrine = tonic contraction + any trimester + raises BP + C/I in hypertension
  3. Misoprostol = oral/SL/vaginal + cervical ripening + any gestation + heat stable + cheap
  4. Carboprost = refractory PPH + C/I in asthma (bronchoconstriction)
  5. Syntometrine = Oxytocin 5 IU + Ergometrine 0.5 mg - used in active management of 3rd stage
  6. Why not ergometrine for induction: tonic contraction → fetal asphyxia + uterus cannot relax + BP rises + cannot stop quickly
  7. Why not oxytocin for PPH alone in resistant cases: short-acting, no vasoconstriction, may need ergometrine's sustained effect
  8. Contraindication to ergometrine: Hypertension (most important), cardiac disease, PVD
  9. "Syntometrine" combines the best of both: fast onset of oxytocin + prolonged effect of ergometrine

Sources: Goodman & Gilman's Pharmacological Basis of Therapeutics; Katzung's Basic & Clinical Pharmacology 16e; KD Tripathi Essentials of Medical Pharmacology (standard classification); Creasy & Resnik's Maternal-Fetal Medicine

/ generate image 3dcutaway on the above content take as much page sand images

Generating Image

3D cutaway medical illustration of the uterus showing oxytocin mechanism of action. Cross-section of uterus with myometrial cells visible inside the wall. Show oxytocin molecules binding to receptors on myometrial cells, with signaling cascade: Gq receptor → phospholipase C → IP3 → calcium release from sarcoplasmic reticulum → MLCK activation → muscle contraction. Show rhythmic wave-like contractions with arrows. Label: oxytocin receptor, Ca2+ ions, IP3 pathway, myometrial fibers contracting rhythmically. Also show posterior pituitary at top releasing oxytocin into bloodstream. Rich anatomical detail, vibrant colors, educational medical poster style, dark background, glowing labels.

Generating Image

3D cutaway medical illustration comparing oxytocin vs ergometrine uterine contractions. Split view of uterus: LEFT HALF shows oxytocin effect - rhythmic wave contractions (sine wave pattern) with relaxation periods between, labeled "RHYTHMIC - safe for fetus", fetal oxygen supply intact, cervix open. RIGHT HALF shows ergometrine effect - sustained tonic clamp contraction, entire uterus squeezed tight like a fist, labeled "TONIC CONTRACTION - fetal asphyxia risk", cervix closed, no relaxation. Show fetus inside for scale. Blood vessels visible. Color coded: oxytocin side blue/green, ergometrine side orange/red. Bold labels, medical education style, dark background.

Generating Image

3D cutaway anatomical illustration showing ergometrine pharmacological basis in postpartum hemorrhage (PPH). Large cross-section of postpartum uterus showing: placental bed with open blood vessels bleeding (red), ergometrine molecules binding to alpha-adrenergic and serotonin 5-HT receptors on uterine muscle cells, resulting in powerful tonic contraction that mechanically compresses placental blood vessels like a living ligature, stopping hemorrhage. Show before/after: left side bleeding open vessels, right side contracted uterus with closed compressed vessels. Label all structures: uterine wall, myometrium, placental site, blood vessels, alpha receptors, 5-HT receptors. Rich 3D detail, vibrant medical poster style.

Generating Image

3D cutaway medical chart infographic showing classification of all oxytocic drugs acting on uterus. Central 3D uterus with 4 branches extending outward: Branch 1 (blue) - Oxytocin: posterior pituitary molecule, IV drip, rhythmic contractions wave; Branch 2 (red) - Ergot Alkaloids: Ergometrine/Methylergometrine, fungus source Claviceps purpurea, tonic contraction clamp icon; Branch 3 (green) - Prostaglandins: PGE2 Dinoprostone, PGE1 Misoprostol pill, PGF2alpha Carboprost injection; Branch 4 (purple) - Miscellaneous: Quinine. Each branch has mechanism icons. Clinical uses listed: induction of labour, PPH, MTP, cervical ripening. Color-coded, 3D depth, bold text labels, dark background, educational poster.

Generating Image

3D cutaway medical illustration explaining why oxytocin is used for induction of labour and NOT methylergometrine. Show pregnant uterus with full-term fetus inside. LEFT PANEL labeled "OXYTOCIN - SAFE FOR INDUCTION": uterus shows rhythmic contractions with relaxation, cervix open and dilating, fetus descending with umbilical cord carrying oxygen (bright red blood), IV drip shown with titration dial, contraction wave graph showing peaks and valleys. RIGHT PANEL labeled "METHYLERGOMETRINE - DANGEROUS": uterus in continuous tonic spasm (red/orange), cervix clamped shut, fetus trapped, umbilical cord compressed (blue = no oxygen), fetal distress symbol, blood pressure arrow going up, danger warning symbols. Very detailed, bold educational style.

Generating Image

3D cutaway medical illustration of prostaglandin analogue misoprostol mechanism on uterus and cervix. Cross-section showing: uterus and cervix in detail. Show misoprostol (PGE1 analogue) binding to EP receptors on myometrial cells and cervical stromal cells. Two effects shown: 1) UTERINE EFFECT - myometrial contractions with calcium signaling cascade, cAMP and IP3 pathways labeled; 2) CERVICAL RIPENING - cervical collagen breakdown, prostaglandin softening the cervix (show collagen fibers dissolving), cervix becoming soft and dilated. Oral pill shown with arrows to multiple routes: oral, sublingual, vaginal, rectal. Heat-stable molecule shown. Side effects bubble: fever thermometer, diarrhea icon. Rich 3D colors, dark background, medical education style.

Generating Image

3D medical comparison table poster: Oxytocin vs Ergometrine vs Misoprostol vs Carboprost - all oxytocics on uterus. Four 3D columns each topped with drug molecule icon. Rows comparing: Source (pituitary gland, fungus, synthetic prostaglandin), Receptor (OT receptor, alpha+5HT, EP receptor, FP receptor), Contraction type (rhythmic wave, tonic clamp, rhythmic+ripening, tonic), Effect on BP (down arrow mild, UP arrow danger red, neutral, up), Oral use (X cross, checkmark green, checkmark green, X), Use in HTN (safe green tick, DANGER red X, safe green tick, safe green tick), Use in Asthma (safe, safe, safe, DANGER red X carboprost bronchospasm), Key use labels. 3D depth shadows, vibrant color coding, bold educational medical poster, dark navy background.

Generating Image

3D cutaway anatomical medical poster showing contraindications of ergometrine. Central 3D uterus with ergometrine molecule. Surrounding it are 8 red danger zones showing contraindications: 1) Hypertension - blood pressure gauge going high with brain stroke icon; 2) Pre-eclampsia/Eclampsia - pregnant woman with swollen face; 3) Heart disease - 3D heart with coronary artery spasm; 4) Peripheral vascular disease - leg with blocked vessel; 5) Fetal presence (induction) - fetus with asphyxia warning; 6) Renal failure - kidney icon; 7) Hepatic failure - liver icon; 8) Migraine - head with pain. Each contraindication shows WHY: vasoconstriction arrows, BP spike graphs, coronary spasm. Bold red warning labels. Dark background, dramatic 3D medical illustration style.

!

400, message: Got more than 4194304 bytes when reading: b'data: {"candidates": [{"content": {"role": "model","parts": [{"inlineData": {"mimeType": "image/png"...'.

We encountered an error while processing your request. Please try again or reach out to us for help.

This is a shared conversation. Sign in to Orris to start your own chat.